Designed with the goal of eliminating
the need for lifelong anticoagulation
Designed with the goal of eliminating
the need for lifelong anticoagulation
ONE VALVE
ONE SURGERY
LIFETIME DURABILITY
ONE VALVE
ONE SURGERY
LIFETIME DURABILITY
ONE VALVE
ONE SURGERY
LIFETIME DURABILITY
ONE VALVE
ONE SURGERY
LIFETIME DURABILITY
A problem no one has solved for decades
Every patient facing replacement has always had to sacrifice something
Mechanical Valves
Lifetime durability
with anticoagulation
Bleeding risk, lifestyle limits, and ongoing monitoring costs that follow the patient forever.
Biological Valves
No anticoagulation
but limited durability
No medication required, but degrades over time. High-risk reoperation inevitable.
Explore our solution
A problem no one has solved for decades
Every patient facing replacement has always had to sacrifice something
Mechanical Valves
Lifetime durability
with anticoagulation
Bleeding risk, lifestyle limits, and ongoing monitoring costs that follow the patient forever.
Biological Valves
No anticoagulation
but limited durability
No medication required, but degrades over time. High-risk reoperation inevitable.
Explore our solution
A problem no one has solved for decades
Every patient facing replacement has always had to sacrifice something
Mechanical Valves
Lifetime durability with anticoagulation
Bleeding risk, lifestyle limits, and ongoing monitoring costs that follow the patient forever.
Biological Valves
No anticoagulation but limited durability
No medication required, but degrades over time.
High-risk reoperation inevitable.
03 — Compatibility
Fully hemocompatible
Designed to work with the body. No platelet activation confirmed in lab.
04 — Engineering
Simulated before built
Advanced fluid dynamics modeling validated the design before the first prototype.
02 — Material
Titanium coated with Titanium Dioxide (TiO₂)
Eliminates platelet activation, the root cause of clotting in mechanical valves.
05— Clinical
Freedom by design
No daily medication. No lifestyle restrictions. No bleeding risk.
01 — Design
Trileaflet architecture
Central and laminar flow. Mimics a healthy natural valve.
Validated in vivo
Early Pre-Clinical Results · France, 2025
Targeting anticoagulation-free outcomes.
Targeting anticoagulation-free outcomes.
Targeting anticoagulation-free outcomes.
30 days without anticoagulation, no adverse events.
90-day ovine study · No structural failure
90-day ovine study ·
No structural failure
Built to outlast the patient,
reoperation-free
Fatigue cycles ~1.5 years in vivo equivalent.
Defensible by design
5
5
Patents granted globally. FTO clearance.
Roadmap
A clear path to
first-in-human
A clear path to
first-in-human
A clear path to first-in-human
Two preclinical studies completed.
Scaling to six before first-in-human
Scaling to six before
first-in-human
Built to outlast the patient,
reoperation-free
Fatigue cycles ~1.5 years in vivo equivalent.
Defensible by design
5
Patents granted globally. FTO clearance.
This device is currently in the early development phase. It is not for sale, commercial distribution, or in any clinical investigation within the US. The device has not been evaluated, cleared, or approved for investigation or sale in the US. Statements regarding the potential safety, efficacy, or performance of the device are subject to ongoing development.
World-class expertise
World-class expertise
Multidisciplinary team with regulatory experience, deep industry connections, and commercialization track record.
Multidisciplinary team with regulatory experience, deep industry connections, and commercialization track record.
Contact Us
Be part of what comes next
One valve. For life.
The engineering behind solving the dilemma
Tap an icon to explore each breakthrough
02 — Material
Titanium coated with Titanium Dioxide (TiO₂)
Eliminates platelet activation, the root cause of clotting in mechanical valves.
One valve. For life.
The engineering behind solving the dilemma
Tap an icon to explore each breakthrough
01 — Design
Trileaflet architecture
Central and laminar flow. Mimics a healthy natural valve.
One valve. For life.
The engineering behind solving the dilemma
Tap an icon to explore each breakthrough
01 — Design
Trileaflet architecture
Central and laminar flow. Mimics a healthy natural valve.